[Intestinal inflammatory diseases].
There was no real therapeutic advances in inflammatory bowel diseases last year. In addition to infliximab, new anti-TNF-alpha agents will soon become available.
Felley
Christian
C
Service de gastro-entérologie et hépatologie, CHUV, 1011 Lausanne.
Mottet
Christian
C
Hess
Jurg
J
Juillerat
Pascal
P
Guyot
Jean
J
Delarive
Joakim
J
Michetti
Pierre
P
D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy*; D015179:Colorectal Neoplasms / Q000209:etiology / Q000517:prevention & control; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans